From FierceAnimalHealth: The annual meeting of the American Association for Cancer Research (AACR) is dedicated to presenting the latest results of promising trials in people–but this year one study that may help both human and canine cancer patients made a splash. During the closely watched conference, held in Philadelphia, researchers from the University of Colorado Cancer Center and Colorado State University Flint Animal Cancer Center presented a gene expression model that veterinarians can use to predict how dogs with osteosarcoma will respond to the commonly used chemo drug doxorubicin. Read more here.